Forward-Looking Statement Disclaimer: This News Release may contain forward-looking information that involves risks and uncertainties, including statements about litigation activities and the anticipated impact of those activities on the Company's results of operations. These forward-looking statements are based upon assumptions made by the Company as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Additional proceedings, including appeals, on the referenced matters are possible which may affect the ultimate outcome of the litigation and associated liability. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. About Hologic, Inc.:

Permanent Contraception in Ghana, Kenya, Mexico, Puerto Rico, and Turkey CHAPEL HILL, N.C., Jan.

Conceptus, Inc. (NASDAQ:CPTS), a leader in the design, development and marketing of innovative women's healthcare has announced a 25 percent growth in 2008 in Essure-trained physicians, the largest number of new physicians in a single year since the launch in 2002.

Conceptus, Inc. (NASDAQ: CPTS) today announced positive results from three clinical studies that were presented at the American Association of Gynecological Laparoscopists (AAGL) 36th Annual Congress.

REDMOND, Wash., May 4 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that Conceptus Inc. has chosen Microsoft Dynamics(TM) CRM 3.0 to help assure the continued growth of the Essure(R) system, Conceptus' flagship medical device.